{"protocolSection":{"identificationModule":{"nctId":"NCT02292251","orgStudyIdInfo":{"id":"IRB00047647"},"organization":{"fullName":"Johns Hopkins University","class":"OTHER"},"briefTitle":"Study to Enhance Motor Acute Recovery With Intensive Training After Stroke","officialTitle":"Study to Enhance Motor Acute Recovery With Intensive Training After Stroke","acronym":"SMARTS2"},"statusModule":{"statusVerifiedDate":"2018-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-05","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-11","type":"ACTUAL"},"completionDateStruct":{"date":"2018-04","type":"ACTUAL"},"studyFirstSubmitDate":"2014-11-08","studyFirstSubmitQcDate":"2014-11-12","studyFirstPostDateStruct":{"date":"2014-11-17","type":"ESTIMATED"},"lastUpdateSubmitDate":"2018-08-08","lastUpdatePostDateStruct":{"date":"2018-08-10","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Johns Hopkins University","class":"OTHER"},"collaborators":[{"name":"Columbia University","class":"OTHER"},{"name":"University of Zurich","class":"OTHER"},{"name":"James S McDonnell Foundation","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"Stroke often results in limitation of arm movements, from which many people do not fully recover. We believe that early and intensive therapy is important to enhance recovery of arm movements after stroke. We are doing this research study to see how much arm movements improve with intensive therapy in patients have had a stroke in the past 6 weeks."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Stroke","Transcranial direct current stimulation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":32,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Device-assisted therapy","type":"ACTIVE_COMPARATOR","description":"30 hours of therapy with the ArmeoPower device, a commercially available device for arm rehabilitation","interventionNames":["Behavioral: Device-assisted therapy"]},{"label":"Therapy-based occupational therapy","type":"ACTIVE_COMPARATOR","description":"30 hours of conventional occupational therapy that emphasizes task-oriented training.","interventionNames":["Behavioral: Therapy-based occupational therapy"]}],"interventions":[{"type":"BEHAVIORAL","name":"Device-assisted therapy","armGroupLabels":["Device-assisted therapy"]},{"type":"BEHAVIORAL","name":"Therapy-based occupational therapy","armGroupLabels":["Therapy-based occupational therapy"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Fugl-Meyer Upper Extremity (FM-UE)","description":"Change in arm impairment, measured by FM-UE","timeFrame":"from baseline to day 3 post-training"}],"secondaryOutcomes":[{"measure":"Fugl-Meyer Upper Extremity (FM-UE)","description":"Change in arm impairment, measured by FM-UE","timeFrame":"from baseline to day 90 post-training"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age over 21 years\n2. Ischemic stroke confirmed by CT or MRI within the previous 6 weeks\n3. No history of prior ischemic or hemorrhagic stroke with associated motor deficits (prior stroke with no motor symptoms is allowed)\n4. Residual unilateral arm weakness with Fugl-Meyer Upper Extremity (FM-UE) score 6-40 at time of enrollment.\n5. Ability to give informed consent and understand the tasks involved.\n\nExclusion Criteria:\n\n1. Space-occupying hemorrhagic transformation or associated intracranial hemorrhage.\n2. Arm impairment that is too severe or too mild on day of baseline testing just prior to beginning of the study intervention.\n3. Recent botox injection to upper limb or planned botox injection over the course of the 7-month study duration.\n4. Cognitive impairment, with score on Montreal Cognitive Assessment (MoCA) â‰¤ 20.\n5. History of physical or neurological condition that interferes with study procedures or assessment of motor function (e.g. severe arthritis, severe neuropathy, Parkinson's disease).\n6. Inability to sit in a chair and perform upper limb exercises for one hour at a time.\n7. Participation in another upper extremity rehabilitative therapy study during the study period.\n8. Terminal illness\n9. Social and/or personal circumstances that interfere with ability to return for therapy sessions and follow up assessments.","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"John W. Krakauer, MD","affiliation":"Johns Hopkins University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Johns Hopkins University","city":"Baltimore","state":"Maryland","zip":"21205","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Columbia University","city":"New York","state":"New York","zip":"10032","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"University of Zurich","city":"Zurich","country":"Switzerland","geoPoint":{"lat":47.36667,"lon":8.54999}}]},"referencesModule":{"references":[{"pmid":"33745372","type":"DERIVED","citation":"Krakauer JW, Kitago T, Goldsmith J, Ahmad O, Roy P, Stein J, Bishop L, Casey K, Valladares B, Harran MD, Cortes JC, Forrence A, Xu J, DeLuzio S, Held JP, Schwarz A, Steiner L, Widmer M, Jordan K, Ludwig D, Moore M, Barbera M, Vora I, Stockley R, Celnik P, Zeiler S, Branscheidt M, Kwakkel G, Luft AR. Comparing a Novel Neuroanimation Experience to Conventional Therapy for High-Dose Intensive Upper-Limb Training in Subacute Stroke: The SMARTS2 Randomized Trial. Neurorehabil Neural Repair. 2021 May;35(5):393-405. doi: 10.1177/15459683211000730. Epub 2021 Mar 20."},{"pmid":"33175411","type":"DERIVED","citation":"Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}